Bain Capital Life Sciences Fund III, L.P.
SEC CIK 1875273 · EDGAR
BoughtSold
Most active insiders at HTFL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bain Capital Life Sciences Investors, LLC | 10% | — | $115.00M |
| 2 | Farquhar John C.M. | CEO, Dir | — | $10.94M |
| 3 | Rogers Campbell | Chief Medical Off | — | $6.71M |
| 4 | Verghese Vikram | CFO | — | $4.98M |
| 5 | Lightcap Jeffrey C | Dir | $1.05M | — |
| 6 | Cullivan Julie A | Dir | — | $446.6K |
| 7 | Jones Marie L. | CAO, VP | — | — |
| 8 | HealthCor Partners Management LP | Dir | — | — |
| 9 | BARABE TIMOTHY C | Dir | — | — |
| 10 | WELDON WILLIAM C | Dir | — | — |
Bain Capital Life Sciences Fund III, L.P. made no open-market trades at HTFL in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-08-13 | 2025-08-11 | HTFL | Heartflow, Inc. | Bain Capital Life Sciences Fund III, L.P. | 10% | C - Cnv Deriv | $15.20 | +12.45M | 12.45M | New | +$189.21M |
| DI | 2024-02-14 | 2024-02-12 | KYTX | Kyverna Therapeutics, Inc. | Bain Capital Life Sciences Fund III, L.P. | 10% | C - Cnv Deriv | — | +2.71M | 2.71M | New | — |
| DI | 2024-02-14 | 2024-02-12 | KYTX | Kyverna Therapeutics, Inc. | Bain Capital Life Sciences Fund III, L.P. | 10% | P - Purchase | $22.00 | +450.0K | 3.16M | +17% | +$9.90M |
Purchase Sale Sale after option exercise All abbreviations